Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy.

This is a a randomized phase II/III trial comparing salvage SBRT with standard of care (SOC) regimens for patients with a persistent detectable PSA or biochemical progression during follow-up after radical prostatectomy.

NCT Number	NCT06523634
Lead Sponsor	Jules Bordet Institute
Conditions	Prostate Cancer
Enrollment	284 participants
Start Date	2024-12-10
Primary Completion	2029-02-01 (estimated)
Study Completion	2032-02-01 (estimated)
Updated on ClinicalTrials.gov	2026-05-12